CYTOREDUCTIVE EFFECT OF RECOMBINANT ALPHA-INTERFERON IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA

被引：44

作者：

BAROSI, G

LIBERATO, LN

COSTA, A

ASCARI, E

机构：

来源：

BLUT | 1989年 / 58卷 / 06期

关键词：

D O I：

10.1007/BF00320164

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：271 / 274

页数：4

共 22 条

[11] HASSELBALCH H, 1988, LANCET, V1, P355
[12] LAZZARINO M, 1987, 31 C SOC IT EM ATT, V1, P101
[13] LUDWIG H, 1987, CANCER IMMUNOL IMMUN, V25, P266
[14] MYELOFIBROSIS - PROGNOSTIC FACTORS AND TREATMENT
MANOHARAN, A
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (03) : 295 - 298
[15] PARMEGGIANI L, 1987, EUR J HAEMATOL, V39, P228
[16] INTERFERON-ALPHA-2 IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS
SEEWANN, HL
GASTL, G
LANG, A
ABBREDERIS, K
THALER, J
FLENER, R
HUBER, C
[J]. BLUT, 1988, 56 (04): : 161 - 163
[17] HEMATOLOGIC REMISSION AND CYTOGENETIC IMPROVEMENT INDUCED BY RECOMBINANT HUMAN INTERFERON-ALPHA-A IN CHRONIC MYELOGENOUS LEUKEMIA
TALPAZ, M
KANTARJIAN, HM
MCCREDIE, K
TRUJILLO, JM
KEATING, MJ
GUTTERMAN, JU
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (17) : 1065 - 1069
[18] HUMAN-LEUKOCYTE INTERFERON TO CONTROL THROMBOCYTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA
TALPAZ, M
MAVLIGIT, G
KEATING, M
WALTERS, RS
GUTTERMAN, JU
[J]. ANNALS OF INTERNAL MEDICINE, 1983, 99 (06) : 789 - 792
[19] TALPAZ M, 1983, BLOOD, V62, P689
[20] WANG JC, 1987, BLOOD, V70, pA188